Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04383145 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Study in Patients With Thoracoabdominal Aortic Aneurysm Treated With the E-nside TAAA Multibranch Stent Graft System

Study acronym: INNER-B
StatusActive, Not Recruiting
PhaseNot specified
SponsorJOTEC GmbH
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Trial status: Recruiting to Active, Not Recruiting
    • Primary completion date changed from estimate of Sep 1, 2024 to Feb 1, 2025
    • Site details revised
    v6
  2. Enrollment target: 200 to 150
    • Primary completion date: Jan 28, 2025 to Sep 1, 2024
    • Eligibility criteria expanded, about 6 words
    • Study site revised
    v5
  3. Eligibility criteria shortened, about 29 wordsv4
  4. Re-verified, no change to tracked fieldsv3
  5. Trial status: Not Yet Recruiting to Recruiting
    • Study sites: 0 to 1
    • Start date changed from estimate of Jun 10, 2020 to Jul 15, 2020
    v2
  6. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
JOTEC GmbH
14 trials monitored
See 1 trial at risk
The INNER-B post-market clinical follow-up study is undertaken to evaluate the prevention of death related to a thoracoabdominal aneurysm when treated by the E-nside TAAA Multibranch Stent Graft System. The secondary objective is to evaluate the safety and clinical performance of the device.
Trial Details
NCT Number NCT04383145
Lead Sponsor JOTEC GmbH
Conditions
(from sponsor)		 Vascular Aneurysm
Related terms Aneurysm
Enrollment 150 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov